Renalytix Reports Full Year Fiscal 2021 Results

Go back to Renalytix Reports Full Year Fiscal 2021 Results

Renalytix AI Plc. (RNLX) PT Lowered to $32 at Stifel

October 22, 2021 7:02 AM EDT

Stifel analyst Daniel Arias lowered the price target on Renalytix AI Plc. (NASDAQ: RNLX) to $32.00 (from $35.00) while maintaining a Buy rating.

The analyst commented, "RNLX finished fiscal 2021 on a familiar ground: the company continues to work through the early days of the KidneyIntelX... More